These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38754310)

  • 1. Discovery of a first-in-class degrader for the protein arginine methyltransferase 6 (PRMT6).
    Yang H; Zhang Q; Zhou S; Hu Z; Tang Q; Li Z; Feng Q; Yu L
    Bioorg Chem; 2024 Jul; 148():107439. PubMed ID: 38754310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a First-in-Class Protein Arginine Methyltransferase 6 (PRMT6) Covalent Inhibitor.
    Shen Y; Li F; Szewczyk MM; Halabelian L; Park KS; Chau I; Dong A; Zeng H; Chen H; Meng F; Barsyte-Lovejoy D; Arrowsmith CH; Brown PJ; Liu J; Vedadi M; Jin J
    J Med Chem; 2020 May; 63(10):5477-5487. PubMed ID: 32367723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of RSL3-based GPX4 degraders with hydrophobic tags.
    Ning Y; Zhu Z; Wang Y; Fan X; Wang J; Qian H; Qiu X; Wang Y
    Eur J Med Chem; 2024 Nov; 277():116719. PubMed ID: 39094276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of antitumor activity of selective PRMT6 inhibitors.
    Zhang Q; Cao J; Zhang Y; Bi Z; Feng Q; Yu L; Li L
    Eur J Med Chem; 2023 Feb; 247():115032. PubMed ID: 36566712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A First-in-Class, Highly Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 6.
    Shen Y; Li F; Szewczyk MM; Halabelian L; Chau I; Eram MS; Dela Seña C; Park KS; Meng F; Chen H; Zeng H; Dong A; Wu H; Trush VV; McLeod D; Zepeda-Velázquez CA; Campbell RM; Mader MM; Watson BM; Schapira M; Arrowsmith CH; Al-Awar R; Barsyte-Lovejoy D; Kaniskan HÜ; Brown PJ; Vedadi M; Jin J
    J Med Chem; 2021 Apr; 64(7):3697-3706. PubMed ID: 33591753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a Potent Class I Protein Arginine Methyltransferase Fragment Inhibitor.
    Ferreira de Freitas R; Eram MS; Szewczyk MM; Steuber H; Smil D; Wu H; Li F; Senisterra G; Dong A; Brown PJ; Hitchcock M; Moosmayer D; Stegmann CM; Egner U; Arrowsmith C; Barsyte-Lovejoy D; Vedadi M; Schapira M
    J Med Chem; 2016 Feb; 59(3):1176-83. PubMed ID: 26824386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6.
    Shen Y; Szewczyk MM; Eram MS; Smil D; Kaniskan HÜ; de Freitas RF; Senisterra G; Li F; Schapira M; Brown PJ; Arrowsmith CH; Barsyte-Lovejoy D; Liu J; Vedadi M; Jin J
    J Med Chem; 2016 Oct; 59(19):9124-9139. PubMed ID: 27584694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic mechanism of protein arginine methyltransferase 6 (PRMT6).
    Obianyo O; Thompson PR
    J Biol Chem; 2012 Feb; 287(8):6062-71. PubMed ID: 22219200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of PRMT6-mediated arginine methylation of p16 protein potentiates its ability to arrest A549 cell proliferation.
    Wang X; Huang Y; Zhao J; Zhang Y; Lu J; Huang B
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2333-41. PubMed ID: 23032699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational Design and Synthesis of Selective PRMT4 Inhibitors: A New Chemotype for Development of Cancer Therapeutics*.
    Sutherland M; Li A; Kaghad A; Panagopoulos D; Li F; Szewczyk M; Smil D; Scholten C; Bouché L; Stellfeld T; Arrowsmith CH; Barsyte D; Vedadi M; Hartung IV; Steuber H; Britton R; Santhakumar V
    ChemMedChem; 2021 Apr; 16(7):1116-1125. PubMed ID: 33513288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of First-in-Class Protein Arginine Methyltransferase 5 (PRMT5) Degraders.
    Shen Y; Gao G; Yu X; Kim H; Wang L; Xie L; Schwarz M; Chen X; Guccione E; Liu J; Bedford MT; Jin J
    J Med Chem; 2020 Sep; 63(17):9977-9989. PubMed ID: 32787082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle regulation by the PRMT6 arginine methyltransferase through repression of cyclin-dependent kinase inhibitors.
    Kleinschmidt MA; de Graaf P; van Teeffelen HA; Timmers HT
    PLoS One; 2012; 7(8):e41446. PubMed ID: 22916108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors.
    Zhu K; Song JL; Tao HR; Cheng ZQ; Jiang CS; Zhang H
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3693-3699. PubMed ID: 30366617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of the PRMT6 modulators in cancer treatment: Current progress and emerged opportunity.
    Peng J; Ni B; Li D; Cheng B; Yang R
    Eur J Med Chem; 2024 Dec; 279():116857. PubMed ID: 39276585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma.
    Liu Z; Lin M; Liu C; Chen X; Chen Q; Li X; Wu X; Wang Y; Wang L; Yang F; Luo C; Jin J; Ye F
    J Med Chem; 2024 Apr; 67(8):6313-6326. PubMed ID: 38574345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCF-FBXO24 regulates cell proliferation by mediating ubiquitination and degradation of PRMT6.
    Chen W; Gao D; Xie L; Wang A; Zhao H; Guo C; Sun Y; Nie Y; Hong A; Xiong S
    Biochem Biophys Res Commun; 2020 Sep; 530(1):75-81. PubMed ID: 32828318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potent DOT1L inhibitors by AlphaLISA based High Throughput Screening assay.
    Song Y; Li L; Chen Y; Liu J; Xiao S; Lian F; Zhang N; Ding H; Zhang Y; Chen K; Jiang H; Zhang C; Liu YC; Chen S; Luo C
    Bioorg Med Chem; 2018 May; 26(8):1751-1758. PubMed ID: 29534934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders.
    Yang X; Wang Z; Pei Y; Song N; Xu L; Feng B; Wang H; Luo X; Hu X; Qiu X; Feng H; Yang Y; Zhou Y; Li J; Zhou B
    Eur J Med Chem; 2021 Jun; 218():113341. PubMed ID: 33780898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of selective protein arginine methyltransferase 5 inhibitors and biological evaluations.
    Ji S; Ma S; Wang WJ; Huang SZ; Wang TQ; Xiang R; Hu YG; Chen Q; Li LL; Yang SY
    Chem Biol Drug Des; 2017 Apr; 89(4):585-598. PubMed ID: 27714957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)--Hit to Lead studies.
    Wan H; Huynh T; Pang S; Geng J; Vaccaro W; Poss MA; Trainor GL; Lorenzi MV; Gottardis M; Jayaraman L; Purandare AV
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5063-6. PubMed ID: 19632837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.